Mission Bio + Innovations in Single-Cell Omics 2026.
May 28–29, 2026 · PRBB Auditorium, Barcelona · Platinum Sponsor
Meet Mission Bio at ISCO 2026 in Barcelona. Discover how the Tapestri Platform is pioneering a new era of single-cell transcriptomics and targeted DNA + RNA analysis to uncover true clonal heterogeneity.
Don’t Miss Our Featured Presentation
Directly Link Genotype to Phenotype | Discover a new era of transcriptomics with
Tapestri DNA + RNA at Single-Cell Resolution.
Speaker: Dr. Avgousta Ioannou, Sr. Field Applications Scientist, Mission Bio.
The Tapestri® Single-Cell Targeted DNA + RNA Assay delivers a multidimensional view of eachcell, linking genotype to phenotype to reveal how genetic variation shapes RNA expression. From complex cancers to engineered cell therapies, Tapestri empowers researchers to uncovermechanisms of action, validate therapeutic edits, and accelerate the path to precision medicine.
Thursday 28th May @ 3:40 PM
Poster Presentation
Innovation in Single-Cell Multi-Omics: Integrated DNA, RNA, Epigenetic, and Lineage Profiling on the Tapestri Platform.
Presented by: Dr. Robert Durruthy-Durruthy, VP Support & Field Applications
Single-cell technologies have transformed our understanding of cellular heterogeneity, yet most approaches fail to directly link genotype to various phenotypes at scale, limiting insight into clonal evolution, disease mechanisms, and therapeutic response.
The Mission Bio Tapestri Platform enables robust co-capture of DNA mutations and other analytes, such as RNA expression from the same single cell through a unique two-step droplet workflow, supporting integrated multi-omic assays across diverse sample types.
Here, we highlight the newly commercialized DNA + RNA assay and demonstrate its application in acute myeloid leukemia, alongside a growing ecosystem of customer-driven and R&D-led multi-omics innovations enabled by the platform.
Thursday May 28th @ 5:50PM
Resources:
The Tapestri Single-cell Multiomics Sequencing Platform is the only system capable of simultaneously providing genotype and immunophenotype data from the same cell, across thousands of cells. With DNA as a foundation, our proprietary two-step microfluidic workflow enables the simultaneous detection of analytes, including SNVs, CNVs, and proteins.





